HMGA2 and colorectal carcinoma: Collectively, this is the first report on the study prescribing CPX as a novel potential inhibitor of HMGA2, which can induce cytotoxicity in CRC cells by inducing cell cycle arrest and apoptosis in vitro and in vivo through direct interaction with the AT-hook motif of HMGA2.